120 related articles for article (PubMed ID: 32602016)
1. Long-chain free fatty acids inhibit ischaemic preconditioning of the isolated rat heart.
Lochner A; Genade S; Genis A; Marais E; Salie R
Mol Cell Biochem; 2020 Oct; 473(1-2):111-132. PubMed ID: 32602016
[TBL] [Abstract][Full Text] [Related]
2. High carbohydrate and high fat diets protect the heart against ischaemia/reperfusion injury.
Salie R; Huisamen B; Lochner A
Cardiovasc Diabetol; 2014 Jul; 13():109. PubMed ID: 25197961
[TBL] [Abstract][Full Text] [Related]
3. Myocardial susceptibility to ischaemia/reperfusion in obesity: a re-evaluation of the effects of age.
Webster I; Salie R; Marais E; Fan WJ; Maarman G; Huisamen B; Lochner A
BMC Physiol; 2017 Mar; 17(1):3. PubMed ID: 28302152
[TBL] [Abstract][Full Text] [Related]
4. Kinases and phosphatases in ischaemic preconditioning: a re-evaluation.
Fan WJ; van Vuuren D; Genade S; Lochner A
Basic Res Cardiol; 2010 Jul; 105(4):495-511. PubMed ID: 20127248
[TBL] [Abstract][Full Text] [Related]
5. Ischemic preconditioning: infarct size is a more reliable endpoint than functional recovery.
Lochner A; Genade S; Moolman JA
Basic Res Cardiol; 2003 Sep; 98(5):337-46. PubMed ID: 12955407
[TBL] [Abstract][Full Text] [Related]
6. Dual effects of dichloroacetate on cardiac ischaemic preconditioning in the rat isolated perfused heart.
Randall MD; Keon CA; Greenhaff PL; Constantin-Teodosiu D
Br J Pharmacol; 1998 May; 124(1):245-51. PubMed ID: 9630366
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of myocardial apoptosis by ischaemic and beta-adrenergic preconditioning is dependent on p38 MAPK.
Moolman JA; Hartley S; Van Wyk J; Marais E; Lochner A
Cardiovasc Drugs Ther; 2006 Feb; 20(1):13-25. PubMed ID: 16552474
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of ischaemic preconditioning in the eNOS overexpressed working mouse heart model.
du Toit EF; Genade S; Carlini S; Moolman JA; Brunner F; Lochner A
Eur J Pharmacol; 2007 Feb; 556(1-3):115-20. PubMed ID: 17157294
[TBL] [Abstract][Full Text] [Related]
9. Differential effect of preconditioning on post-ischaemic myocardial performance in the absence of substantial infarction and in extensively infarcted rat hearts.
Efstathiou A; Seraskeris S; Papakonstantinou C; Aidonopoulos A; Lazou A
Eur J Cardiothorac Surg; 2001 Apr; 19(4):493-9. PubMed ID: 11306319
[TBL] [Abstract][Full Text] [Related]
10. Myocardial adenosine does not correlate with the protection mediated by ischaemic or pharmacological preconditioning in rat heart.
Vasara E; Katharou I; Lazou A
Clin Exp Pharmacol Physiol; 2003; 30(5-6):350-6. PubMed ID: 12859425
[TBL] [Abstract][Full Text] [Related]
11. The significance of the washout period in preconditioning.
Salie R; Lochner A; Loubser DJ
Cardiovasc Ther; 2017 Jun; 35(3):. PubMed ID: 28118517
[TBL] [Abstract][Full Text] [Related]
12. L-Arginine given after ischaemic preconditioning can enhance cardioprotection in isolated rat hearts.
Suematsu Y; Ohtsuka T; Hirata Y; Maeda K; Imanaka K; Takamoto S
Eur J Cardiothorac Surg; 2001 Jun; 19(6):873-9. PubMed ID: 11404145
[TBL] [Abstract][Full Text] [Related]
13. p38 MAPK activation triggers pharmacologically-induced beta-adrenergic preconditioning, but not ischaemic preconditioning.
Marais E; Genade S; Strijdom H; Moolman JA; Lochner A
J Mol Cell Cardiol; 2001 Dec; 33(12):2157-77. PubMed ID: 11735262
[TBL] [Abstract][Full Text] [Related]
14. Effects of fatty acids on cardioprotection by pre-ischaemic inhibition of the malate-aspartate shuttle.
Dalgas C; Povlsen JA; Løfgren B; Erichsen SB; Bøtker HE
Clin Exp Pharmacol Physiol; 2012 Oct; 39(10):878-85. PubMed ID: 22831462
[TBL] [Abstract][Full Text] [Related]
15. Infarct-remodelled hearts with limited oxidative capacity boost fatty acid oxidation after conditioning against ischaemia/reperfusion injury.
Lou PH; Zhang L; Lucchinetti E; Heck M; Affolter A; Gandhi M; Kienesberger PC; Hersberger M; Clanachan AS; Zaugg M
Cardiovasc Res; 2013 Feb; 97(2):251-61. PubMed ID: 23097573
[TBL] [Abstract][Full Text] [Related]
16. Lipid peroxidation, arachidonic acid and products of the lipoxygenase pathway in ischaemic preconditioning of rat heart.
Starkopf J; Andreasen TV; Bugge E; Ytrehus K
Cardiovasc Res; 1998 Jan; 37(1):66-75. PubMed ID: 9539859
[TBL] [Abstract][Full Text] [Related]
17. Activation of p38 MAPK induced by a multi-cycle ischaemic preconditioning protocol is associated with attenuated p38 MAPK activity during sustained ischaemia and reperfusion.
Marais E; Genade S; Huisamen B; Strijdom JG; Moolman JA; Lochner A
J Mol Cell Cardiol; 2001 Apr; 33(4):769-78. PubMed ID: 11273729
[TBL] [Abstract][Full Text] [Related]
18. Manipulations in glycogen metabolism and the failure to influence infarct size in the ischaemic rabbit heart.
Gozal Y; Wolff RA; Van Winkle DM
Eur J Anaesthesiol; 2002 Jul; 19(7):495-503. PubMed ID: 12113612
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of the malate-aspartate shuttle by pre-ischaemic aminooxyacetate loading of the heart induces cardioprotection.
Støttrup NB; Løfgren B; Birkler RD; Nielsen JM; Wang L; Caldarone CA; Kristiansen SB; Contractor H; Johannsen M; Bøtker HE; Nielsen TT
Cardiovasc Res; 2010 Nov; 88(2):257-66. PubMed ID: 20562422
[TBL] [Abstract][Full Text] [Related]
20. CREB activation and ischaemic preconditioning.
Marais E; Genade S; Lochner A
Cardiovasc Drugs Ther; 2008 Feb; 22(1):3-17. PubMed ID: 18205034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
